Oxime and hydroxylamine substituted thiazolo (4,5-c) ring compounds and methods

Details for Australian Patent Application No. 2006338521 (hide)

Owner Coley Pharmaceutical Group, Inc.

Inventors Lundquist, Gregory D. Jr.; Heppner, Philip D.; Kshirsagar, Tusher A.

Agent Davies Collison Cave

Pub. Number AU-A-2006338521

Priority 60/651,845 09.02.05 US

Filing date 8 February 2006

Wipo publication date 11 October 2007

International Classifications

A61K 31/00 (2006.01)

Event Publications

11 October 2007 Application Open to Public Inspection

  Published as AU-A-2006338521

11 October 2007 PCT application entered the National Phase

31 July 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Coley Pharmaceutical Group, Inc., Application No. 2006338521, under INID(43), correct the date to read 25.10.07

5 March 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Coley Pharmaceutical Group, Inc., Application No. 2006338521, under INID(43), correct the date to read 25.10.07

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006338523-Methods and compositions related to heightened APOBEC-1 related protein (ARP) expression

2006338510-Oral care regimens and devices